
Global Ureteroscopy Market Report and Forecast 2024-2032
Description
Global Ureteroscopy Market Report and Forecast 2024-2032
Global Ureteroscopy Market Report and Forecast 2024-2032
The global ureteroscopy market was valued at USD 1.05 billion in 2023. It is expected to grow at a CAGR of 5.1% during the forecast period of 2024-2032 and attain a value of USD 1.64 billion by 2032. The market is driven by increasing prevalence of urinary tract stones and rising preference for minimally invasive surgeries across the globe.
Global Ureteroscopy Market Analysis
Ureteroscopy is a minimally invasive procedure used to diagnose and treat conditions affecting the urinary tract, particularly the ureters and kidneys. Utilising a ureteroscope, a thin, flexible instrument equipped with a camera and tools, urologists can visually inspect the ureters and perform various interventions such as stone removal, biopsy, and the treatment of strictures or tumours. The global ureteroscopy market has been witnessing significant growth due to the rising prevalence of urological disorders, advancements in ureteroscopy technology, and increasing demand for minimally invasive surgical procedures.
Market Drivers
- Rising Prevalence of Urological Disorders: The increasing incidence of kidney stones, ureteral strictures, and urinary tract infections drives the demand for ureteroscopy procedures. Lifestyle changes, dietary habits, and an ageing population contribute to the growing number of urological conditions, necessitating effective diagnostic and therapeutic options.
- Technological Advancements: Innovations in ureteroscopy equipment, such as the development of flexible and digital ureteroscopes, have enhanced the precision and efficacy of procedures. High-definition imaging and improved manoeuvrability allow for better visualisation and treatment of urological conditions, boosting the adoption of ureteroscopy.
- Preference for Minimally Invasive Procedures: Minimally invasive techniques like ureteroscopy offer several benefits over traditional open surgeries, including reduced recovery times, lower risk of complications, and shorter hospital stays. Patients and healthcare providers increasingly prefer these advantages, driving the market's growth.
- Increasing Healthcare Expenditure: Growing investments in healthcare infrastructure, particularly in emerging economies, have expanded access to advanced medical technologies. This trend supports the uptake of ureteroscopy procedures and equipment, contributing to market expansion.
- High Cost of Equipment: Ureteroscopy equipment, including ureteroscopes and associated accessories, can be expensive. The high cost may limit adoption, particularly in low-income regions or healthcare facilities with budget constraints.
- Lack of Skilled Professionals: Performing ureteroscopy requires specialised training and expertise. A shortage of skilled urologists and trained healthcare personnel in certain regions can hinder the market's growth, as effective treatment outcomes depend on the proficiency of the operator.
- Risk of Complications: Despite being minimally invasive, ureteroscopy procedures carry risks such as infection, bleeding, and ureteral injury. These potential complications may deter patients and healthcare providers from opting for ureteroscopy, especially when alternative treatment options are available.
- Expansion in Emerging Markets: Rapid urbanisation, increasing healthcare awareness, and improving economic conditions in emerging markets present significant growth opportunities for the ureteroscopy market. Companies can expand their presence in these regions by offering cost-effective and innovative solutions tailored to local needs.
- Integration of Artificial Intelligence (AI): The incorporation of AI and machine learning in ureteroscopy procedures can enhance diagnostic accuracy and treatment outcomes. AI-powered tools can assist in real-time image analysis, predictive analytics, and decision-making, improving the efficiency and effectiveness of ureteroscopy.
- Development of Disposable Ureteroscopes: To address the challenges of equipment cost and infection risk, the development and adoption of single-use, disposable ureteroscopes are gaining traction. These devices eliminate the need for sterilisation, reduce the risk of cross-contamination, and can be more cost-effective in the long run.
- Telemedicine and Remote Assistance: The growing acceptance of telemedicine can facilitate remote consultations and support for ureteroscopy procedures. Expert urologists can provide guidance and oversight to less experienced practitioners in real-time, improving access to specialised care and enhancing procedural outcomes.
Ureteroscopy is a pivotal procedure in the management of urological disorders, offering minimally invasive solutions for diagnosing and treating conditions affecting the urinary tract. The global ureteroscopy market is evolving rapidly, driven by technological advancements and increasing demand for efficient, patient-friendly medical interventions.
Market Trends
- Technological Integration: The ureteroscopy market is witnessing significant advancements in technology, with the integration of high-definition imaging, digital ureteroscopes, and laser lithotripsy tools. These innovations enhance procedural accuracy, reduce operation times, and improve patient outcomes. Manufacturers are focusing on developing flexible and durable ureteroscopes to cater to the growing demand for precision and reliability in urological procedures.
- Rise of Single-Use Ureteroscopes: To address the challenges of cross-contamination and equipment sterilisation, the market is seeing a shift towards single-use, disposable ureteroscopes. These devices offer a cost-effective and convenient alternative, particularly in regions with limited access to advanced sterilisation facilities. The adoption of disposable ureteroscopes is expected to grow, driven by their potential to reduce infection rates and streamline operational workflows.
- AI and Robotics Integration: The incorporation of artificial intelligence (AI) and robotic assistance in ureteroscopy procedures is an emerging trend. AI-powered tools can assist in real-time image analysis, enhancing diagnostic accuracy and treatment planning. Robotic systems improve the precision and control of surgical instruments, making complex procedures more manageable and reducing the risk of human error.
- Growing Preference for Minimally Invasive Techniques: Patients and healthcare providers are increasingly favouring minimally invasive procedures due to their numerous benefits, including reduced pain, shorter recovery times, and minimal scarring. Ureteroscopy, being a minimally invasive technique, is gaining traction as a preferred choice for treating various urological conditions. This trend is expected to continue, bolstering market growth.
- Telemedicine and Remote Assistance: The advent of telemedicine is revolutionising the healthcare landscape, including the field of ureteroscopy. Remote consultations and tele-mentoring are becoming more prevalent, allowing urologists to provide expert guidance and support to practitioners performing ureteroscopy procedures in real-time. This trend enhances access to specialised care, particularly in remote or underserved regions.
- Expansion in Emerging Markets: The ureteroscopy market is experiencing significant growth in emerging economies due to improving healthcare infrastructure, rising awareness of urological health, and increasing disposable incomes. Companies are investing in these regions, offering cost-effective and innovative ureteroscopy solutions tailored to local healthcare needs. This expansion is expected to drive market growth and create new opportunities for stakeholders.
Market Breakup by Type
- Flexible Ureteroscopes
- Semi-rigid Ureteroscopes
- Rigid Ureteroscopes
Market Breakup by Application
- Kidney Cancer
- Urolithiasis
- Urinary Stricture
- Others
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Ureteroscopy Market Competitive Landscape
The global ureteroscopy market is highly competitive, with key players including Storz Medical AG, Boston Scientific Corporation, Elmed Medical Systems, Rocamed, Olympus Corporation, OTU Medical Inc., Cook Medical, Accel Medical, and Stryker. These companies are actively engaged in mergers and acquisitions to expand their market presence and enhance their product portfolios. Research initiatives focus on advancing ureteroscopy technology, improving imaging capabilities, and developing single-use devices. Frequent product introductions aim to address the growing demand for minimally invasive procedures. Strategic partnerships and collaborations are also common, facilitating technological innovation and expanding market reach. Collectively, these activities contribute to the dynamic growth and competitive nature of the ureteroscopy market.
Key Questions Answered in the Report
- What is the current and future performance of the ureteroscopy market?
- What are the main challenges facing the ureteroscopy market?
- What are the key drivers of the ureteroscopy market?
- What emerging trends are shaping the future of the ureteroscopy market?
- What factors are expected to propel future growth in the ureteroscopy market?
- What factors are anticipated to drive future growth in the ureteroscopy market?
- What is driving growth in specialty clinics and ambulatory surgery centres within the ureteroscopy market?
- Why do North America and Europe dominate the ureteroscopy market?
- What are the common strategies used by key players in the ureteroscopy market?
- The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global ureteroscopy market from 2017-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the ureteroscopy market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the ureteroscopy industry and its attractiveness.
- The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Ureteroscopy Market Overview
- 3.1 Global Ureteroscopy Market Historical Value (2017-2023)
- 3.2 Global Ureteroscopy Market Forecast Value (2024-2032)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Ureteroscopy Market Landscape*
- 5.1 Global Ureteroscopy: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Ureteroscopy: Product Landscape
- 5.2.1 Analysis by Type
- 6 Global Ureteroscopy Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Ureteroscopy Market, Epidemiology Snapshot
- 7.1 Overview of Global Ureteroscopy Incidence Number (2017-2032)
- 7.2 Incidence Number, By Indication (2017-2032)
- 7.2.1 Kidney Cancer
- 7.2.2 Urolithiasis
- 7.2.3 Urinary Stricture
- 7.2.4 Others
- 8 Global Ureteroscopy Market Segmentation (2017-2032)
- 8.1 Global Ureteroscopy Market (2017-2032) by Type
- 8.1.1 Market Overview
- 8.1.2 Flexible Ureteroscopes
- 8.1.3 Semi-rigid Ureteroscopes
- 8.1.4 Rigid Ureteroscopes
- 8.2 Global Ureteroscopy Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Kidney Cancer
- 8.2.3 Urolithiasis
- 8.2.4 Urinary Stricture
- 8.2.5 Others
- 8.3 Global Ureteroscopy Market (2017-2032) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals
- 8.3.3 Specialty Clinics
- 8.3.4 Ambulatory Surgery Centers
- 8.3.5 Others
- 8.4 Global Ureteroscopy Market (2017-2032) by Region
- 8.4.1 Market Overview
- 8.4.2 North America
- 8.4.3 Europe
- 8.4.4 Asia Pacific
- 8.4.5 Latin America
- 8.4.6 Middle East and Africa
- 9 North America Ureteroscopy Market (2017-2032)
- 9.1 North America Ureteroscopy Market (2017-2032) by Type
- 9.1.1 Market Overview
- 9.1.2 Flexible Ureteroscopes
- 9.1.3 Semi-rigid Ureteroscopes
- 9.1.4 Rigid Ureteroscopes
- 9.2 North America Ureteroscopy Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Kidney Cancer
- 9.2.3 Urolithiasis
- 9.2.4 Urinary Stricture
- 9.2.5 Others
- 9.3 North America Ureteroscopy Market (2017-2032) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals
- 9.3.3 Specialty Clinics
- 9.3.4 Ambulatory Surgery Centers
- 9.3.5 Others
- 9.4 North America Ureteroscopy Market (2017-2032) by Country
- 9.4.1 United States of America
- 9.4.2 Canada
- 10 Europe Ureteroscopy Market (2017-2032)
- 10.1 Europe Ureteroscopy Market (2017-2032) by Type
- 10.1.1 Market Overview
- 10.1.2 Flexible Ureteroscopes
- 10.1.3 Semi-rigid Ureteroscopes
- 10.1.4 Rigid Ureteroscopes
- 10.2 Europe Ureteroscopy Market (2017-2032) by Application
- 10.2.1 Market Overview
- 10.2.2 Kidney Cancer
- 10.2.3 Urolithiasis
- 10.2.4 Urinary Stricture
- 10.2.5 Others
- 10.3 Europe Ureteroscopy Market (2017-2032) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals
- 10.3.3 Specialty Clinics
- 10.3.4 Ambulatory Surgery Centers
- 10.3.5 Others
- 10.4 Europe Ureteroscopy Market (2017-2032) by Country
- 10.4.1 United Kingdom
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 Italy
- 10.4.5 Others
- 11 Asia Pacific Ureteroscopy Market (2017-2032)
- 11.1 Asia Pacific Ureteroscopy Market (2017-2032) by Type
- 11.1.1 Market Overview
- 11.1.2 Flexible Ureteroscopes
- 11.1.3 Semi-rigid Ureteroscopes
- 11.1.4 Rigid Ureteroscopes
- 11.2 Asia Pacific Ureteroscopy Market (2017-2032) by Application
- 11.2.1 Market Overview
- 11.2.2 Kidney Cancer
- 11.2.3 Urolithiasis
- 11.2.4 Urinary Stricture
- 11.2.5 Others
- 11.3 Asia Pacific Ureteroscopy Market (2017-2032) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals
- 11.3.3 Specialty Clinics
- 11.3.4 Ambulatory Surgery Centers
- 11.3.5 Others
- 11.4 Asia Pacific Ureteroscopy Market (2017-2032) by Country
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 ASEAN
- 11.4.5 Australia
- 11.4.6 Others
- 12 Latin America Ureteroscopy Market (2017-2032)
- 12.1 Latin America Ureteroscopy Market (2017-2032) by Type
- 12.1.1 Market Overview
- 12.1.2 Flexible Ureteroscopes
- 12.1.3 Semi-rigid Ureteroscopes
- 12.1.4 Rigid Ureteroscopes
- 12.2 Latin America Ureteroscopy Market (2017-2032) by Application
- 12.2.1 Market Overview
- 12.2.2 Kidney Cancer
- 12.2.3 Urolithiasis
- 12.2.4 Urinary Stricture
- 12.2.5 Others
- 12.3 Latin America Ureteroscopy Market (2017-2032) by End User
- 12.3.1 Market Overview
- 12.3.2 Hospitals
- 12.3.3 Specialty Clinics
- 12.3.4 Ambulatory Surgery Centers
- 12.3.5 Others
- 12.4 Latin America Ureteroscopy Market (2017-2032) by Country
- 12.4.1 Brazil
- 12.4.2 Argentina
- 12.4.3 Mexico
- 12.4.4 Others
- 13 Middle East and Africa Ureteroscopy Market (2017-2032)
- 13.1 Middle East and Africa Ureteroscopy Market (2017-2032) by Type
- 13.1.1 Market Overview
- 13.1.2 Flexible Ureteroscopes
- 13.1.3 Semi-rigid Ureteroscopes
- 13.1.4 Rigid Ureteroscopes
- 13.2 Middle East and Africa Ureteroscopy Market (2017-2032) by Application
- 13.2.1 Market Overview
- 13.2.2 Kidney Cancer
- 13.2.3 Urolithiasis
- 13.2.4 Urinary Stricture
- 13.2.5 Others
- 13.3 Middle East and Africa Ureteroscopy Market (2017-2032) by End User
- 13.3.1 Market Overview
- 13.3.2 Hospitals
- 13.3.3 Specialty Clinics
- 13.3.4 Ambulatory Surgery Centers
- 13.3.5 Others
- 13.4 Middle East and Africa Ureteroscopy Market (2017-2032) by Country
- 13.4.1 Saudi Arabia
- 13.4.2 United Arab Emirates
- 13.4.3 Nigeria
- 13.4.4 South Africa
- 13.4.5 Others
- 14 Regulatory Framework
- 14.1 Regulatory Overview
- 14.2 US FDA
- 14.3 EU EMA
- 14.4 INDIA CDSCO
- 14.5 JAPAN PMDA
- 14.6 Others
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership and Collaborations
- 16.3 Analysis by Joint Ventures
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia-Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Storz Medical AG
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Boston Scientific Corporation
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Elmed Medical Systems
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Rocamed
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Olympus Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 OTU Medical Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Cook Medical
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Accel Medical
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Stryker
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 18 Global Ureteroscopy Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- **The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.